Developer docs
API playgroundTry for free, no card

Search company profiles

DSM Biomedical

Full company profile

uuid003cbqs

Namestring
DSM Biomedical
Legal namestring
dsm-firmenich
Websiteurl
dsm.com
Company typeenum
Private
Founded yearint
2000
Descriptiontext

DSM Biomedical is a specialized biomaterials business unit of dsm-firmenich, headquartered in Exton, Pennsylvania, and operating as a supplier of biocomposite and resorbable orthopedic devices along with ceramics, coatings, and polyethylenes for medical applications. The unit focuses on biocompatible coating technologies for implantable medical devices, with primary emphasis on cardiovascular and orthopedic end uses, and an emerging footprint in regenerative medicine and 3D-printed biomaterials.

Its technical foundation is in proprietary biocompatible coating formulations and process know-how developed over a heritage traceable to Royal DSM (the company was reorganized into the dsm-firmenich group following Royal DSM's 2023 merger-of-equals with Firmenich). The value proposition centers on enabling implant integration, durability, and regulatory compliance for device manufacturers, with domain specialization in coatings cited as the core differentiator.

DSM Biomedical operates as a B2B component supplier to medical device manufacturers rather than as a downstream provider to end patients, generating revenue through undisclosed commercial terms under which its coatings and biomaterials are specified into customer devices. Go-to-market is conducted via direct relationships with medical implant OEMs and through participation in the broader biocompatible coating ecosystem alongside named peers SurModics, BioInteractions, and Biocoat. Pricing, contract terms, and unit-level revenue figures are not publicly disclosed; the business is reported as part of dsm-firmenich's consolidated financials on Euronext Amsterdam.

Short descriptiontext

DSM Biomedical is a dsm-firmenich business unit that supplies biomaterials and biocompatible coatings to medical device manufacturers for cardiovascular, orthopedic, and regenerative medicine applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersExton, United States
HQ citystring
Exton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
biocompatible coatings, medical device biomaterials, resorbable orthopedic devices, biocomposite materials, implantable device materials
Industry3 codes
1Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom)
CodeIMANAFACPrimaryYes
2Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates)
CodeIMAEAOALPrimaryNo
3Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
CodeIMAAADAGPrimaryNo
NAICS code3 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing33911
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Medical Device Biomaterials
Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

DSM Biomedical supplies biocompatible coatings, biocomposites, resorbable polymers, ceramics, and medical-grade polyethylenes used by manufacturers of implantable medical devices. Its materials are incorporated into cardiovascular and orthopedic implants, as well as regenerative medicine applications, where biocompatibility, controlled resorption, and regulatory compliance are required.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

DSM Biomedical operates as a biomaterials company focused on developing and commercializing advanced biomedical solutions. The company is part of the dsm-firmenich corporate group and competes in the biocompatible coating market alongside companies such as SurModics, BioInteractions, and Biocoat. No specific individual product names, modules, or product architecture details are provided in the available sources.

Product and service6 records
1Biocompatible Coatings for Medical Devices
CategoryBiocompatible Coatings
Description

Advanced coating technologies applied to medical implants and devices to provide biocompatible surfaces for cardiovascular and orthopedic applications, sold to medical device manufacturers.

2Biocomposite Materials
CategoryBiomaterials
Description

Composite biomaterial systems used in orthopedic implantable devices, combining reinforcing phases with biocompatible matrices for medical device manufacturers.

3Resorbable Orthopedic Devices and Polymers
CategoryResorbable Biomaterials
Description

Resorbable polymer-based orthopedic devices that are gradually absorbed by the body, eliminating the need for secondary removal surgery, supplied to orthopedic implant manufacturers.

4Ceramic Biomaterials for Medical Implants
CategoryCeramic Biomaterials
Description

Medical-grade ceramic biomaterials used in orthopedic implant manufacturing where biocompatibility and mechanical performance are required.

5Medical-Grade Polyethylenes
CategoryPolyethylene Biomaterials
Description

Medical-grade polyethylene materials supplied for use in implantable orthopedic devices manufactured by medical device OEMs.

6Regenerative Medicine Biomaterials
CategoryRegenerative Medicine Biomaterials
Description

Biomaterial inputs for regenerative medicine applications such as tissue regeneration, organ replacement, and 3D-printed constructs, sold to companies developing regenerative medicine therapies.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers8 records
TypeBroad incumbent
Description

Corbion is a major biomaterials company with bioresorbable polymers and biomedical materials used in medical implants and tissue engineering — a broad incumbent competing in adjacent biomaterial categories.

TypeDirect peer
Description

SurModics is a leading developer of surface modification technologies, including biocompatible coatings for vascular and orthopedic devices — directly competing with DSM Biomedical in the same customer base and end applications.

TypeDirect peer
Description

BioInteractions develops biocompatible and antimicrobial coating technologies for medical devices, particularly cardiovascular and orthopedic implants — a directly comparable peer cited alongside DSM Biomedical in the market.

TypeDirect peer
Description

Covalon Technologies develops antimicrobial and biocompatible coating technologies for wound care and medical devices — a directly comparable peer in the medical coating space.

TypeBroad incumbent
Description

Evonik is a large specialty chemicals company with a significant healthcare materials portfolio including bioresorbable polymers (RESOMER) and medical-grade biomaterials — a broad incumbent that overlaps with DSM Biomedical's resorbable materials and coatings.

TypeDirect peer
Description

Biocoat specializes in hydrophilic and other functional coatings for medical devices including guidewires, catheters, and delivery systems — directly comparable to DSM Biomedical's coating business.

TypeDirect peer
Description

Hydromer develops hydrophilic and antimicrobial coating formulations for medical devices and implants, addressing the same biocompatible coatings niche as DSM Biomedical.

TypeDirect peer
Description

Poly-Med specializes in bioresorbable polymers and fibers for medical implants and tissue engineering — directly comparable to DSM Biomedical's resorbable biomaterials and regenerative medicine focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DSM Biomedical

Medical Device Biomaterialsdsm.com

DSM Biomedical is a dsm-firmenich business unit that supplies biomaterials and biocompatible coatings to medical device manufacturers for cardiovascular, orthopedic, and regenerative medicine applications.

What DSM Biomedical does

DSM Biomedical is a specialized biomaterials business unit of dsm-firmenich, headquartered in Exton, Pennsylvania, and operating as a supplier of biocomposite and resorbable orthopedic devices along with ceramics, coatings, and polyethylenes for medical applications. The unit focuses on biocompatible coating technologies for implantable medical devices, with primary emphasis on cardiovascular and orthopedic end uses, and an emerging footprint in regenerative medicine and 3D-printed biomaterials.

Its technical foundation is in proprietary biocompatible coating formulations and process know-how developed over a heritage traceable to Royal DSM (the company was reorganized into the dsm-firmenich group following Royal DSM's 2023 merger-of-equals with Firmenich). The value proposition centers on enabling implant integration, durability, and regulatory compliance for device manufacturers, with domain specialization in coatings cited as the core differentiator.

DSM Biomedical operates as a B2B component supplier to medical device manufacturers rather than as a downstream provider to end patients, generating revenue through undisclosed commercial terms under which its coatings and biomaterials are specified into customer devices. Go-to-market is conducted via direct relationships with medical implant OEMs and through participation in the broader biocompatible coating ecosystem alongside named peers SurModics, BioInteractions, and Biocoat. Pricing, contract terms, and unit-level revenue figures are not publicly disclosed; the business is reported as part of dsm-firmenich's consolidated financials on Euronext Amsterdam.

DSM Biomedical firmographics

Firmographics
Name
DSM Biomedical
Legal name
dsm-firmenich
Website
https://dsm.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
DSM Biomedical is a dsm-firmenich business unit that supplies biomaterials and biocompatible coatings to medical device manufacturers for cardiovascular, orthopedic, and regenerative medicine applications.
Ownership category
akta.pro rank

DSM Biomedical industry classification

Industry
Product category
Medical Device Biomaterials
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (33911)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro primary industry
Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom) (IMANAFAC)
akta.pro secondary industries
Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates) (IMAEAOAL), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)

Keywords

  • Biocompatible coatings
  • Medical device biomaterials
  • Resorbable orthopedic devices
  • Biocomposite materials
  • Implantable device materials

Where DSM Biomedical is headquartered

Location

Headquarters

HQ city
Exton
HQ country
United States
HQ region
North America

Markets served

DSM Biomedical business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

DSM Biomedical product offering

Product offering

Core offering

DSM Biomedical supplies biocompatible coatings, biocomposites, resorbable polymers, ceramics, and medical-grade polyethylenes used by manufacturers of implantable medical devices. Its materials are incorporated into cardiovascular and orthopedic implants, as well as regenerative medicine applications, where biocompatibility, controlled resorption, and regulatory compliance are required.

Product overview

DSM Biomedical operates as a biomaterials company focused on developing and commercializing advanced biomedical solutions. The company is part of the dsm-firmenich corporate group and competes in the biocompatible coating market alongside companies such as SurModics, BioInteractions, and Biocoat. No specific individual product names, modules, or product architecture details are provided in the available sources.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biocompatible Coatings for Medical Devices Advanced coating technologies applied to medical implants and devices to provide biocompatible surfaces for cardiovascular and orthopedic applications, sold to medical device manufacturers.
  • Biocomposite Materials Composite biomaterial systems used in orthopedic implantable devices, combining reinforcing phases with biocompatible matrices for medical device manufacturers.
  • Resorbable Orthopedic Devices and Polymers Resorbable polymer-based orthopedic devices that are gradually absorbed by the body, eliminating the need for secondary removal surgery, supplied to orthopedic implant manufacturers.
  • Ceramic Biomaterials for Medical Implants Medical-grade ceramic biomaterials used in orthopedic implant manufacturing where biocompatibility and mechanical performance are required.
  • Medical-Grade Polyethylenes Medical-grade polyethylene materials supplied for use in implantable orthopedic devices manufactured by medical device OEMs.
  • Regenerative Medicine Biomaterials Biomaterial inputs for regenerative medicine applications such as tissue regeneration, organ replacement, and 3D-printed constructs, sold to companies developing regenerative medicine therapies.

Companies that use DSM Biomedical

Customer profile

Segments2 records

Ideal customer profiles2 records

DSM Biomedical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

DSM Biomedical partnerships and signals

Strategic signal

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

DSM Biomedical competitors and assessment

Company assessment

Broad incumbents

  • Corbion: Corbion is a major biomaterials company with bioresorbable polymers and biomedical materials used in medical implants and tissue engineering — a broad incumbent competing in adjacent biomaterial categories.
  • Evonik: Evonik is a large specialty chemicals company with a significant healthcare materials portfolio including bioresorbable polymers (RESOMER) and medical-grade biomaterials — a broad incumbent that overlaps with DSM Biomedical's resorbable materials and coatings.

Direct peers

  • SurModics: SurModics is a leading developer of surface modification technologies, including biocompatible coatings for vascular and orthopedic devices — directly competing with DSM Biomedical in the same customer base and end applications.
  • BioInteractions: BioInteractions develops biocompatible and antimicrobial coating technologies for medical devices, particularly cardiovascular and orthopedic implants — a directly comparable peer cited alongside DSM Biomedical in the market.
  • Covalon Technologies: Covalon Technologies develops antimicrobial and biocompatible coating technologies for wound care and medical devices — a directly comparable peer in the medical coating space.
  • Biocoat: Biocoat specializes in hydrophilic and other functional coatings for medical devices including guidewires, catheters, and delivery systems — directly comparable to DSM Biomedical's coating business.
  • Hydromer: Hydromer develops hydrophilic and antimicrobial coating formulations for medical devices and implants, addressing the same biocompatible coatings niche as DSM Biomedical.
  • Poly-Med: Poly-Med specializes in bioresorbable polymers and fibers for medical implants and tissue engineering — directly comparable to DSM Biomedical's resorbable biomaterials and regenerative medicine focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

DSM Biomedical social profiles

Digital presence

DSM Biomedical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DSM Biomedical leadership team

Management profile

Number of profiles

Profiles1 record

DSM Biomedical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DSM Biomedical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DSM Biomedical

What does DSM Biomedical do?

DSM Biomedical supplies biocompatible coatings, biocomposites, resorbable polymers, ceramics, and medical-grade polyethylenes used by manufacturers of implantable medical devices. Its materials are incorporated into cardiovascular and orthopedic implants, as well as regenerative medicine applications, where biocompatibility, controlled resorption, and regulatory compliance are required.

Is DSM Biomedical a public or private company?

DSM Biomedical is a private company. It is classified as corporate owned and is currently operating.

When was DSM Biomedical founded?

DSM Biomedical was founded in 2000. It employs 5,001 to 10,000 people.

Where is DSM Biomedical based?

DSM Biomedical is headquartered in Exton, United States, in the North America region.

Who are DSM Biomedical's main competitors?

Broad incumbents on record are Corbion and Evonik. Direct peers are SurModics, BioInteractions, Covalon Technologies, Biocoat, Hydromer and Poly-Med.

Does DSM Biomedical have an API?

No public API is recorded for DSM Biomedical.

What industry is DSM Biomedical in?

DSM Biomedical's product category is Medical Device Biomaterials. Its primary akta.pro industry code is IMANAFAC, Medical & Life Sciences Injection Molding (Devices, Diagnostics, Cleanroom), with a secondary code of IMAEAOAL, Biodegradable Medical & Hygiene Materials (absorbables, disposables substrates). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
LinkedInPrecision Coating MarketKey Insights, Trends, Drivers, and Regional Growth FactorsThe global precision coating market, valued at USD 9.52 billion in 2024, is projected to reach USD 15.74 billion by 2033, growing at a CAGR of 6.05%. This expansion is driven by technological advancements in nanotechnology, increasing demand from aerospace and automotive sectors for lightweight materials, and stricter environmental regulations promoting eco-friendly coatings. Key industry players such as DSM Biomedical, Surmodics, and Specialty Coating Systems are actively shaping the competitive landscape through innovation and strategic adaptation.PR NewswireGlobal Medical Hydrophilic and Hydrophobic Coatings Market, Forecast to 2023A market report forecasts growth in the global medical hydrophilic and hydrophobic coatings sector through 2023, driven by the rising preference for minimally invasive surgery and increased awareness of healthcare-associated infections. Key industry participants include Surmodics, which leads the hydrophilic segment, and companies such as Specialty Coating Systems, DSM Biomedical, and Bicoat Incorporated operating across both coating types. The report highlights technological advancements like antimicrobial parylene technology and UV-curing serine coatings as primary factors influencing market dynamics.PR NewswireActamax™ Submits IDE to FDA for Pivotal Study on Novel Sprayable Adhesion Barrier DeviceActamax Surgical Materials LLC, a subsidiary of DSM Biomedical, submitted an Investigational Device Exemption (IDE) to the FDA in February 2017 to conduct a pivotal clinical trial for its Actamax™ Adhesion Barrier in gynecological laparoscopic surgery. The device previously demonstrated safety and efficacy in a 78-patient multi-center study with 12-month follow-up data showing lower recurrence rates of pre-study symptoms and higher pregnancy rates in treated patients. The company stated it worked with the FDA during pre-submission meetings to address questions and concerns before filing the application.PR NewswireMedical Device Coatings Market Analysis By Product (Hydrophilic, Antimicrobial, Drug-Eluting, Anti-Thrombogenic), By Application (Neurology, Orthopedics, General Surgery, Cardiovascular, Dentistry, GyGrand View Research published a market analysis projecting the global medical device coatings market to reach USD 15.69 billion by 2025, driven by growing demand for coatings that improve biocompatibility between living tissue and medical devices. The report identifies key growth drivers including rising preference for implantable medical equipment, technological innovations such as antimicrobial coatings for orthopedic implants, and expanding healthcare infrastructure in Asia Pacific and Central & South America. The industry features major players including SurModics Inc., DSM Biomedical, Hydromer Inc., Biocoat Inc., and Sono-Tek Corp., with Asia Pacific accounting for 20.3% of global revenue in 2015.PR NewswireMarkets for Smart Antimicrobial Coatings and Surfaces - 2015 to 2022ReportLinker published a market research report by n-tech analyzing the smart antimicrobial coatings and surfaces industry from 2015 to 2022. The report details technologies such as nanosilver and graphene, forecasts revenue growth across sectors like healthcare and consumer electronics, and profiles strategic activities of key firms including Dow Corning and DSM Biomedical.